Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
54.47
+0.68 (+1.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Why Lantheus (LNTH) Stock Is Falling Today
August 13, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 3.1% on continued negative momentum after a downgrade by Truist Securities, which cited concerns over competitive pressures...
Via
StockStory
Topics
Artificial Intelligence
Why Lantheus (LNTH) Stock Is Falling Today
August 12, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 4.7% in the afternoon session after Truist Securities downgraded the stock from a "Buy" to a "Hold" rating and slashed its...
Via
StockStory
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
August 12, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...
Via
Benzinga
Earnings Scheduled For August 6, 2025
August 06, 2025
Via
Benzinga
What Does the Market Think About Lantheus Holdings?
July 04, 2025
Via
Benzinga
4 Analysts Assess Lantheus Holdings: What You Need To Know
August 12, 2025
Via
Benzinga
LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook
August 12, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year revenue...
Via
StockStory
Lantheus (LNTH) Q2 Revenue Falls 4%
August 06, 2025
Via
The Motley Fool
What's going on in today's session
August 06, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Nasdaq Surges 1%; Uber Sales Top Estimates
August 06, 2025
Via
Benzinga
Why Lantheus (LNTH) Stock Is Falling Today
August 06, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 29.8% in the afternoon session after the company reported disappointing second-quarter financial results and slashed its...
Via
StockStory
Topics
Lawsuit
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 06, 2025
Via
Benzinga
Here are the top movers in Wednesday's session.
August 06, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
The market is filled with gapping stocks in Wednesday's session.
August 06, 2025
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings
August 06, 2025
Via
Benzinga
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Shares Plunge 20.8% After Q2 2025 Earnings Miss and Weak Guidance
August 06, 2025
Lantheus Holdings (LNTH) Q2 2025 earnings miss estimates, revenue down 4.1%. Shares drop 20.8% as weak guidance raises concerns. FDA accepts NDA for PYLARIFY upgrade.
Via
Chartmill
Topics
Earnings
Discover the top movers in Wednesday's pre-market session.
August 06, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 06, 2025
Via
Benzinga
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8%
August 06, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year...
Via
StockStory
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
August 06, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings
August 04, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Wednesday before market hours. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Government
World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): A Prime Value Investment with Strong Fundamentals
August 04, 2025
Lantheus Holdings (LNTH) is a standout value stock with strong financials, low P/E ratios, and high profitability, making it an attractive pick for value investors.
Via
Chartmill
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
July 23, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
July 22, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...
Via
StockStory
Topics
Lawsuit
World Trade
Why Is Lantheus Stock Trading Lower On Wednesday?
July 16, 2025
CMS proposes a $140 drug packaging threshold and a $655 diagnostic radiopharmaceutical threshold for CY 2026, using inflation-adjusted PPI data.
Via
Benzinga
Why Lantheus (LNTH) Stock Is Down Today
July 16, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition...
Via
StockStory
Topics
ETFs
Stocks
World Trade
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
July 11, 2025
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Via
StockStory
Topics
ETFs
Stocks
World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
July 05, 2025
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued healthcare stock with strong profitability, financial health, and reasonable growth potential, making it a candidate for value investors.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.